STAT+: GlaxoSmithKline’s Emma Walmsley predicts a ‘landmark’ 2022 for the company
Next year will be a “landmark” one for GlaxoSmithKline, according to CEO Emma Walmsley —…
Next year will be a “landmark” one for GlaxoSmithKline, according to CEO Emma Walmsley —…